Saturday, October 31, 2026

JD.com Stock Surges Over 28% In Recent 10-Session Rally

JD.com Stock Surges Over 28% In Recent 10-Session Rally

(VIANEWS) - JD.com Inc. (NASDAQ: JD) saw its shares experience a dramatic 28.03% upswing over the past 10 trading sessions, rising from EUR21.44 to EUR27.45; an uptick that followed an overall downward trend from previous session. Meanwhile, NASDAQ is currently down 0.96% at EUR15,973.17 - marking two consecutive sessions of losses; JD's last closing price at EUR27.05.05 represented a 40.1% decrease from its 52-week high of EUR45.16

About JD.com

JD.com Inc, China's premier e-commerce platform, offers an impressive array of products and services including supply chain technologies, marketplace services, marketing services and omni-channel solutions. JD provides electronics, home appliances, furniture, cosmetics, pharmaceuticals as well as online healthcare services, logistics facilities management asset management services real estate properties for sale as part of their offerings. JD was established in Beijing back in 2006 with its headquarters based there as well.

Yearly Analysis

Based on the provided data, here is the investment outlook for JD.com: Yearly Top and Bottom Value At EUR27.45, the current stock price is significantly below its 52-week high of EUR45.16 and indicates a decrease in value over the past year. Yet it remains above its 52-week low of EUR20.82 suggesting some recovery. JD.com anticipates annual sales growth of 6.6% this year and 6.4% for 2019. However, its expected expansion of its logistics network, technological investments, and product offerings should drive this modest expansion. Earnings Before Interest, Taxes, Depreciation, and Amortization JD.com has reported an EBITDA score of 2.09 which indicates it is generating positive cash flow from its operations - an encouraging sign for its financial health and suggests they could potentially reinvest it back into their business to spur future expansion. JD.com may not boast as high of an expected growth rate as other tech companies, but its positive cash flow and continued investments suggest long-term potential for expansion. Before making any decisions or investing any funds in any way, however, thorough research should always be performed and consideration given to all relevant factors before taking the leap.

Technical Analysis

JD.com stock has experienced an ongoing downward trend, currently trading below its 200-day moving average of EUR29.90 but significantly above its 50-day moving average of EUR23.95. This could indicate that JD.com stock is experiencing a short-term correction after experiencing strong growth over the past period. With last reported volume being 17,519,173, this could indicate it has seen above its average volume of 15,714,500 and thus be undergoing a short-term correction. The stochastic oscillator, a popular technical indicator, classifies JD.com stock as oversold with an oscillator reading below 20, suggesting it may experience an upward swing soon. Investors should keep in mind that stock prices can be affected by many variables and therefore perform additional research before making investment decisions.

Quarter Analysis

Sales GrowthJD.com currently holds sales growth at 6.6% for this quarter and 10.9% projected for next. Growth Estimates QuartersJD.com has growth estimates that are negative 1.5% for the current quarter while their estimated positive 1.3% estimates for next. Recurring Revenue GrowthOver the past 12 months, JD.com experienced year-on-year quarterly revenue growth at 3.6% with current revenues standing at $1.08T.

Equity Analysis

JD.com appears to be an economic contender with an adequate dividend yield and reasonable valuation, an estimated forward annual dividend yield of 3.07% not being particularly high nor too low. JD.com boasts an attractive trailing twelve months EPS figure of EUR2.12, an excellent return. Furthermore, its PE ratio of 12.95 indicates that JD.com does not overprice its earnings relative to its market cap. JD.com's return on equity of 8.15% for the twelve trailing months is an encouraging sign, signalling that they are making substantial profits relative to shareholder equity. Overall, JD.com appears to be a stable company with sound financials that could make an attractive investment opportunity for those seeking moderate returns. Before making your final decision though, it's wise to conduct further research and assess both personal goals and risk tolerance before taking the plunge.

More news about JD.com (JD).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com